CAP Member William Charles McDonald, MD, FCAP, discusses biomarkers in cancer testing. “The markers have a reasonable chance of giving us a tool, a handle, something with which we can guide therapy and increase our likelihood of successful treatment with reduced side effects,” said Dr. McDonald.
For the full article click here: How biomarkers are changing brain tumor diagnoses and treatments